Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins

International Immunopharmacology
Edson L SantosJoão B Pesquero

Abstract

In the kallikrein-kinin and renin-angiotensin systems the main receptors, B1 and B2 (kinin receptors) and AT1 and AT2 (angiotensin receptors) respectively, are seven-transmembrane domain G-protein-coupled receptors. Considering that the B1 agonists Des-Arg9-BK (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe), Lys-desArg9-BK or Des-Arg10-KD (Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe) and the AT1 agonist (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) have the same two residues at the C-terminal region (i.e. Pro-Phe), we hypothesized that TM V and TM VI of the B1 receptor could play an essential role in agonist binding and activity, being these regions receptor sites for binding the C-terminal sequences of Des-Arg-kinins similarly to that observed to AT1 receptor. To investigate this hypothesis, we replaced Arg212 for Ala at the top of the TM V and the sequence 274-282 (CPYHFFAFL) in TM VI of the rat kinin B1 receptor by the B2 receptor homologous sequence, 289-297 (FPFQISTFL) and subsequently analyzed the consequences of these mutations by competition binding and functional assays. Despite correct expression, observed at the mRNA and protein level by RT-PCR and confocal microscopy, respectively, no agonist binding and function was verified for the mutated recepto...Continue Reading

References

Sep 30, 1992·Biochemical and Biophysical Research Communications·Y YamanoT Inagami
Aug 1, 1992·British Journal of Rheumatology·K D BhoolaP A Dieppe
Jun 1, 1989·Trends in Pharmacological Sciences·A DeBlasiH J Motulsky
Dec 1, 1995·The Journal of Biological Chemistry·K NodaS S Karnik
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·J Nardone, P G Hogan
Jun 1, 1996·Immunopharmacology·B A Schölkens
Mar 6, 1999·The Journal of Biological Chemistry·S MiuraS S Karnik
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·J B PesqueroM Bader
Aug 5, 2000·Science·K PalczewskiM Miyano
Mar 22, 2001·Biological Chemistry·D RegoliF Gobeil
Jan 24, 2002·Circulation·Costanza EmanueliPaolo Madeddu
Apr 23, 2005·Biochemical and Biophysical Research Communications·Sookhee N HaFred J Hess
Feb 27, 2007·Regulatory Peptides·Edson L SantosJoão B Pesquero
Apr 13, 2007·Physiological Reviews·Laerte OliveiraAntonio C M Paiva

❮ Previous
Next ❯

Citations

Jan 24, 2016·Journal of Pharmacological and Toxicological Methods·Renan P MartinSuma I Shimuta
Jun 25, 2009·Biochemical Pharmacology·Edson Lucas SantosJoão Bosco Pesquero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.